Pharmaceutical News Headlines for July 5 2012 ( Thursday )


• Up to 2,000 Jobs to Go at Sanofi (France) (SAN.PA) More...

• Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories, Ltd. More...

• Provepharm Continues Its International Expansion by Signing Three New Distribution Agreements in Europe More...

• Calixar and Synthelis Team Up to Provide Unique Membrane Protein Services More...

• The Leukemia & Lymphoma Society and Celator Pharmaceuticals, Inc. Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML More...

• Prosonix Enters Collaboration With Imperial College London to Accelerate Development of Engineered Combination Respiratory Medicines (Multi-component Particles™, MCPs™) More...

• Cardiome Pharma Corp. (COM.TO) CEO Leaves in the Middle of Company Reorg. More...

• Mytrus Appoints Anthony Costello as CEO More...

• Cipla Ltd. Hires Former Teva Pharmaceutical Industries Limited (TEVA) V.P. to Run European Respiratory Biz More...

• Arena Pharmaceuticals, Inc. (ARNA) Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs More...

• Alain Schwenck, an Expert on Pharmaceutical Production, Becomes Director of Genethon Bioprod More...

• Hi-Tech Pharmacal (HITK) to Release Fourth Quarter Earnings and Hold Conference Call on July 10, 2012 More...

• IntelliPharmaCeutics Announces Second Quarter 2012 Results More...

• Thermo Fisher Scientific (TMO) to Hold Earnings Conference Call on Wednesday, July 25, 2012 More...

• Dr. Drew Responds to News He Was Paid by GlaxoSmithKline (GSK) More...

• Merck KGaA (MKGAF.PK) Drug Fails in Stomach Cancer Trial More...

• Pharming Group (PHGUF.PK) Completes Recruitment of RUCONEST® US Pivotal Phase III Study More...

• BioTie Therapies Corp. Completes Enrollment in Phase 2b Trial of Tozadenant in Parkinson's Disease More...

• Ultragenyx Initiates Phase 2 Study of UX001 in Hereditary Inclusion Body Myopathy, a Rare Neuromuscular Disease More...

• MorphoSys AG Partner OncoMed Pharmaceuticals, Inc. Publishes Data on HuCAL Antibody OMP-18R5 More...

• Bedford Laboratories Issues Nationwide Voluntary Hospital/User-Level Recall of Leucovorin Calcium Injection More...

• Skyepharma PLC (SKYEF)'s Asthma Drug Gets European Marketing Nod More...

• Sucampo Pharmaceuticals, Inc., Abbott Laboratories (ABT) Announce Approval for AMITIZA® in Japan More...

• Optimer Pharmaceuticals, Inc. (OPTR)r's DIFICID&#0174 (fidaxomicin) Tablets Approved by Health Canada for the Treatment of Clostridium Difficile Infection and Now Available to Canadian Patients More...

• Lupin Ltd. (LUPN.BO) Receives FDA Approval for Generic LYRICA® More...

• Actavis Receives Tentative Approval of Generic Intuniv® (Guanfacine Extended-Release Tablets) in the US More...

• Johnson & Johnson (JNJ) Pulls File to Extend Velcade's Use in EU More...

• Diabetes Drug Elevates Bladder Cancer Risk, University of Alberta Study More...

• Heavy Coffee Intake May Affect Fertility Treatments, Aarhus University Study More...

• Getting Married or Having a Child Makes You Less Satisfied at Work, Kingston University Study More...

• Higher Doses of Vitamin D Prevent Fractures in Older Women, University of Zurich Study More...

• Massage Right After Muscle Injury May Boost Healing, Ohio State University Medical Center Study More...
Tags: , ,

About author

Make it happen !!

0 comments

Leave a Reply